Nava Health MD (NAVA) S-1/A IPO registration (amended)

Exhibit 107

Calculation of Filing Fee Tables

FORM S-1

(Form Type)

NAVA HEALTH MD, LLC

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation or Carry Forward Rule	Amount Registered		Proposed Maximum Offering Price Per Unit		Proposed Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Newly Registered Securities
Fees to be Paid	Equity	Common Stock, $0.01 par value per share(2)(3)	Rule 457(o)		—		—	$	10,867,500	$	0.00011020	$	1,197.60
	Equity	Representative’s Warrants(4)	Rule 457(g)		—		—		—	$	0.00011020		—
	Equity	Common Stock Underlying Representative’s Warrants(5)	Rule 457(g)		—		—	$	921,375	$	0.00011020	$	101.54
	Equity	Common Stock, $0.01 par value per share, to be sold by the selling stockholders(6)	Rule 457(o)		—		—	$	9,673,566	$	0.00011020	$	1,066.03
Fees Previously Paid												$	1,924.64
Carry Forward Securities
Carry Forward Securities
	Total Offering Amounts							$	21,462,441	$	0.00011020	$	2,365.17
	Total Fees Previously Paid											$	1,924.64
	Total Fees Offsets												—
	Net Fee Due											$	440.53

(1)	Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended.
(2)	Pursuant to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, distributions, recapitalizations or other similar transactions.
(3)	Includes the offering price of shares of common stock that the representative of the underwriter has the option to purchase to cover over-allotments, if any.
(4)	No fee required pursuant to Rule 457(g) under the Securities Act.
(5)	Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The representative’s warrants are exercisable at a per share exercise price equal to 130% of the public offering price. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative’s warrants is $921,375, which is equal to 130% of $708,750 (which is 7.5% of $9,450,000, the proposed maximum offering price excluding the offering price of shares of common stock that the representative of the underwriter has the option to purchase to cover over-allotments and the price of shares of common stock held by selling stockholders).
(6)	This registration statement also covers the resale by certain selling stockholders named in the registration statement of shares of Common Stock previously issued to such selling stockholders as described in the registration statement.